ZA200903898B - Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors - Google Patents
Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitorsInfo
- Publication number
- ZA200903898B ZA200903898B ZA200903898A ZA200903898A ZA200903898B ZA 200903898 B ZA200903898 B ZA 200903898B ZA 200903898 A ZA200903898 A ZA 200903898A ZA 200903898 A ZA200903898 A ZA 200903898A ZA 200903898 B ZA200903898 B ZA 200903898B
- Authority
- ZA
- South Africa
- Prior art keywords
- parp
- adp
- ribose
- polymerase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts, stereoisomers or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory discuses, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo and/or radiosensitizers for cancer treatment.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0700432.8A GB0700432D0 (en) | 2007-01-10 | 2007-01-10 | Therapeutic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200903898B true ZA200903898B (en) | 2010-04-28 |
Family
ID=37809722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200903898A ZA200903898B (en) | 2007-01-10 | 2009-06-04 | Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors |
Country Status (21)
Country | Link |
---|---|
CN (1) | CN101578279B (en) |
AT (1) | ATE502933T1 (en) |
CR (1) | CR10910A (en) |
DE (1) | DE602008005711D1 (en) |
DK (2) | DK2336120T3 (en) |
ES (3) | ES2362214T3 (en) |
GB (1) | GB0700432D0 (en) |
HN (1) | HN2009001260A (en) |
HU (1) | HUE044513T2 (en) |
LT (1) | LT2805945T (en) |
LU (1) | LUC00072I2 (en) |
ME (1) | ME03481B (en) |
MY (1) | MY147789A (en) |
NI (1) | NI200900135A (en) |
NZ (1) | NZ578256A (en) |
PE (1) | PE20081558A1 (en) |
PT (3) | PT2805945T (en) |
SI (2) | SI2336120T1 (en) |
TW (1) | TWI528961B (en) |
UA (1) | UA97658C2 (en) |
ZA (1) | ZA200903898B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106496187A (en) * | 2016-09-14 | 2017-03-15 | 陕西科技大学 | A kind of synthetic method for preparing PARP inhibitor Niraparib |
CN106432188A (en) * | 2016-09-17 | 2017-02-22 | 青岛辰达生物科技有限公司 | Preparation method of anti-cancer drug 2-[4-((3S)-3-Piperidinyl) phenyl]-2H-Indazole-7-Formamide |
CN106432187A (en) * | 2016-09-17 | 2017-02-22 | 青岛云天生物技术有限公司 | Chiral resolution method of 2-[4-(-3-piperidyl)phenyl]-2H-indazole-7-formamide |
CN106632244A (en) * | 2016-09-30 | 2017-05-10 | 陕西科技大学 | A novel synthetic method for preparing an anticancer medicine Niraparib |
CN106467513A (en) * | 2016-09-30 | 2017-03-01 | 陕西科技大学 | A kind of synthetic method preparing Niraparib |
CN108201537A (en) * | 2016-12-16 | 2018-06-26 | 苏州苏融生物医药有限公司 | A kind of Ni Lapani sustained and controlled release medicaments composition and application thereof |
KR20190130625A (en) * | 2017-03-27 | 2019-11-22 | 테사로, 인코포레이티드 | Niraprip formulation |
CN109081828B (en) * | 2017-06-14 | 2021-03-26 | 上海时莱生物技术有限公司 | Poly (ADP-ribose) polymerase inhibitor, preparation method and application |
EP3687505A1 (en) | 2017-09-26 | 2020-08-05 | Tesaro Inc. | Niraparib formulations |
CN108084157A (en) * | 2018-02-12 | 2018-05-29 | 安庆奇创药业有限公司 | A kind of synthetic method of Ni Lapani |
CN108203404A (en) * | 2018-03-02 | 2018-06-26 | 上海博邦医药科技有限公司 | (R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani |
CA3169303A1 (en) | 2020-02-24 | 2021-09-02 | Xiaokun SHEN | Application of poly adp-ribose polymerase inhibitors in corona virus resistance |
CN115611860A (en) * | 2021-07-13 | 2023-01-17 | 上海博璞诺科技发展有限公司 | Method for synthesizing nilapanib |
-
2007
- 2007-01-10 GB GBGB0700432.8A patent/GB0700432D0/en not_active Ceased
-
2008
- 2008-01-08 SI SI200831266T patent/SI2336120T1/en unknown
- 2008-01-08 PT PT14176452T patent/PT2805945T/en unknown
- 2008-01-08 HU HUE14176452 patent/HUE044513T2/en unknown
- 2008-01-08 DK DK11157369.7T patent/DK2336120T3/en active
- 2008-01-08 ES ES08702101T patent/ES2362214T3/en active Active
- 2008-01-08 LT LTEP14176452.2T patent/LT2805945T/en unknown
- 2008-01-08 DK DK08702101.0T patent/DK2109608T3/en active
- 2008-01-08 PT PT08702101T patent/PT2109608E/en unknown
- 2008-01-08 ME MEP-2019-147A patent/ME03481B/en unknown
- 2008-01-08 TW TW097100730A patent/TWI528961B/en active
- 2008-01-08 SI SI200830240T patent/SI2109608T1/en unknown
- 2008-01-08 UA UAA200908335A patent/UA97658C2/en unknown
- 2008-01-08 PT PT111573697T patent/PT2336120E/en unknown
- 2008-01-08 NZ NZ578256A patent/NZ578256A/en unknown
- 2008-01-08 AT AT08702101T patent/ATE502933T1/en active
- 2008-01-08 DE DE602008005711T patent/DE602008005711D1/en active Active
- 2008-01-08 ES ES11157369.7T patent/ES2509115T3/en active Active
- 2008-01-08 ES ES14176452T patent/ES2728199T3/en active Active
- 2008-01-08 MY MYPI20092876A patent/MY147789A/en unknown
- 2008-01-08 PE PE2008000097A patent/PE20081558A1/en active IP Right Grant
- 2008-01-08 CN CN2008800019265A patent/CN101578279B/en active Active
-
2009
- 2009-06-04 ZA ZA200903898A patent/ZA200903898B/en unknown
- 2009-07-02 NI NI200900135A patent/NI200900135A/en unknown
- 2009-07-02 HN HN2009001260A patent/HN2009001260A/en unknown
- 2009-07-02 CR CR10910A patent/CR10910A/en unknown
-
2018
- 2018-05-03 LU LU00072C patent/LUC00072I2/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE602008005711D1 (en) | 2011-05-05 |
CR10910A (en) | 2010-01-19 |
GB0700432D0 (en) | 2007-02-21 |
LUC00072I2 (en) | 2018-07-04 |
ATE502933T1 (en) | 2011-04-15 |
PT2109608E (en) | 2011-05-30 |
CN101578279B (en) | 2013-07-17 |
NI200900135A (en) | 2010-08-30 |
TW200836731A (en) | 2008-09-16 |
MY147789A (en) | 2013-01-31 |
ES2362214T3 (en) | 2011-06-29 |
DK2109608T3 (en) | 2011-07-11 |
NZ578256A (en) | 2011-12-22 |
HUE044513T2 (en) | 2019-10-28 |
LT2805945T (en) | 2019-06-25 |
TWI528961B (en) | 2016-04-11 |
CN101578279A (en) | 2009-11-11 |
ES2509115T3 (en) | 2014-10-17 |
SI2109608T1 (en) | 2011-07-29 |
ME03481B (en) | 2020-01-20 |
UA97658C2 (en) | 2012-03-12 |
ES2728199T3 (en) | 2019-10-22 |
PT2805945T (en) | 2019-06-06 |
SI2336120T1 (en) | 2014-10-30 |
PT2336120E (en) | 2014-10-01 |
HN2009001260A (en) | 2012-03-26 |
DK2336120T3 (en) | 2014-10-06 |
PE20081558A1 (en) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009007200A (en) | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors. | |
ZA200903898B (en) | Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors | |
MX2010005070A (en) | Pyridazinone derivatives as parp inhibitors. | |
WO2007138351A3 (en) | Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) | |
MX2012002179A (en) | Heterocyclic oxime compounds. | |
WO2008103277A3 (en) | Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors | |
MX2013001204A (en) | Compounds for the treatment/prevention of ocular inflammatory diseases. | |
ATE543811T1 (en) | PYRIDAZINE DERIVATIVES AS FACTOR XIA INHIBITORS | |
EA201190158A1 (en) | Derivatives of benzofuranyl for use as glucose kinase inhibitors | |
WO2010045251A3 (en) | Spiro-oxindole compounds and their use as therapeutic agents | |
MX2011011854A (en) | Dihydropyrimidinones for use as bace2 inhibitors. | |
MX2012001838A (en) | Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation. | |
WO2008017883A3 (en) | 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) | |
EA201070864A1 (en) | NEW HETEROCYCLIC COMPOUNDS | |
WO2011147951A8 (en) | Cycloamino derivatives as gpr119 agonists | |
MX2011013869A (en) | Anthelmintic agents and their use. | |
PH12015500418A1 (en) | Pyridine derivative and medicine | |
TR201901937T4 (en) | 8-methyl-1-phenyl-imidazole [1,5-a] pyrazine compounds. |